Pear Therapeutics Announces FDA Submission for Somryst™, a Prescription Digital Therapeutic for the Treatment of Adults with Chronic Insomnia and Depression
Pear Therapeutics today announced the filing of a submission to the U.S. Food and Drug…
Arboretum_JDJuly 18, 2019